openPR Logo
Press release

Biopharma PEG Provides Multi-arm PEG Derivatives Crosslinked Into Hydrogels

Biopharma PEG Provides Multi-arm PEG Derivatives Crosslinked

Polyethylene (ethylene glycol) is a hydrophilic polymer that can have a very high water content when cross-linked into a network. Polyethylene glycol (PEG) is a suitable material for biological applications because it does not normally elicit an immune response. Since the 1970s, PEG has been used to modify therapeutic proteins and peptides in order to increase their solubility, reduce their toxicity, and prolong their cyclic half-lives. In the late 1970s, researchers began to experiment with PEG hydrogels for cell cultures. PEG hydrogels are chemically well-defined, and multiple chemistries can be used both for their formation and chemical modification.

PEG is readily synthesized by the living anionic ring-opening polymerization of ethylene oxide; well-defined (low polydispersity) PEGs with a range of molecular weights and a variety of end groups (e.g., alcohol, methyl ether, amine, N-hydroxysuccinimidyl (NHS) ester) are widely available.

In order to form hydrogels, PEG must be cross-linked. Initially, PEG was nonspecifically cross-linked using ionizing radiation. PEG hydrogels are now commonly synthesized by covalent cross-linking of PEG macromers with reactive chain ends.

At present, PEG has been widely used as hydrogels, and it is expected that future application prospects will also be quite broad. Biopharma PEG provides high-quality activated multi-arm PEG derivatives including 4-arm and 8-arm PEG products as following with special structures which can be crosslinked into degradable PEG hydrogels.

4-ArmPEG succinimidyl glutarate (4-ArmPEG-SG) are high quality multi-arm PEG derivatives with succinimidyl ester at each terminal of the four arms, which can be crosslinked into degradable PEG hydrogels. PEG hydrogels have a variety of applications in medical devices and regenerative medicine, and are especially of interest for controlled release of drugs, for 2D and 3D cell culture, and for wound sealing and healing.

4-ArmPEG succinimidyl succinate (4-arm PEG-SS) is a high-quality multi-arm PEG derivative with succinimidyl succinate at each terminal of the four arms connected to one pentaerythritol core. It can be crosslinked into degradable PEG hydrogels, which can be used in medical devices and regenerative medicine, and are especially of interest for controlled release of drugs, for 2D and 3D cell culture, and for wound sealing and healing. 4-arm PEG-SS is available with molecular weights of 2K, 5K, 10K, 20K Da. Other MW may be available by custom synthesis.

8-ArmPEG-Succinimidyl Glutarate ester (8-Arm PEG-SG) is a multiarmed PEG derivative with succinimidyl NHS ester groups at each terminal of the eight arms connected to one hexaglycerol core, which can be crosslinked into degradable PEG hydrogels. PEG hydrogels have a variety of applications in medical devices and regenerative medicine, and are especially of interest for controlled release of drugs, for 2D and 3D cell culture, and for wound sealing and healing. PEG-SG (succinimidyl glutarate ester) is one type of PEG-NHS reagents. There is a C4 hydrocarbon ester linkage between PEG and the NHS ester.

8 Arm PEG Succinimidyl Succinate (8-arm PEG-SS) derivatives can be cross-linked into degradable PEG hydrogels. It is a cleavable PEG linker. The cleavable ester linker between PEG and NHS ester enables the feature of degradable hydrogels, which can be used in medical devices and regenerative medicine, and are especially of interest for controlled release of drugs, for 2D and 3D cell culture, and for wound sealing and healing. 8-arm PEG-SS is available with molecular weights of 2K, 5K, 10K, 20K Da. Other MW may be available by custom synthesis.

Biopharma PEG Scientific Inc.
Address: 108 Water Street, Room 4D, Watertown, MA 02472, USA
TEL: 1-857-366-6766
Fax: 617-206-9595
Email: sales@biochempeg.com
Website: https://www.biochempeg.com/

Biopharma PEG Scientific Inc. is a biotechnology-oriented company in Watertown, Massachusetts. We are dedicated to manufacturing and supplying high purity monodispersed and polydispersed polyethylene glycol (PEG) derivatives and PEG raw material, PEGylation services, and custom PEG derivative synthesis to clients worldwide. We continuously expand the capability to provide large-scale manufacture of high purity PEG derivatives with an extensive variety of functional groups, in both non-GMP and GMP grade. These PEG linkers have been widely used in bioconjugation, antibody-drug conjugates (ADCs) therapeutic, click chemistry, 3d bioprinting, drug delivery and diagnostics field, etc. 

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biopharma PEG Provides Multi-arm PEG Derivatives Crosslinked Into Hydrogels here

News-ID: 2822895 • Views:

More Releases from Biochempeg Scientific Inc.

Semaglutide VS Liraglutide: Which Is Better For Weight Loss
Semaglutide VS Liraglutide: Which Is Better For Weight Loss
Among adults with overweight or obesity, once-weekly subcutaneous semaglutide plus counseling for diet and physical activity results in significantly greater weight loss at 68 weeks than once-daily subcutaneous liraglutide, according to a study published in the Jan. 11 issue of the Journal of the American Medical Association. Domenica M. Rubino, M.D., from the Washington Center for Weight Management and Research in Arlington, Virginia, and colleagues compared the efficacy and adverse event
What Are Components And Mechanism Action of Antibody-Drug Conjugates
What Are Components And Mechanism Action of Antibody-Drug Conjugates
Antibody-Drug Conjugates (ADC) is a type of anticancer drug that links a drug to cancer-targeting antibodies. The antibody detects tumor-specific proteins expressed on cancer cells and directs the cytotoxic anticancer drug towards the cancer cell. Compared to alternative cancer treatments, for example, chemotherapy, immunotherapy, radiation, and stem cell therapy, ADC combines chemotherapy and immunotherapy and allows selective delivery of anticancer drugs and reduces systemic exposure and toxicity of anticancer drugs. Components of ADC One
Sacituzumab govitecan shows promise in treating the most aggressive type of breast cancer
Sacituzumab govitecan shows promise in treating the most aggressive type of brea …
A unique antibody drug conjugate (ADC), which delivers a high dose of a cancer-killing drug to tumor cells through a targeted antibody, has been found in a global phase 3 clinical study to nearly double the survival time of patients with refractory metastatic triple-negative breast cancer. The study of the ADC drug sacituzumab govitecan (SG), for which Massachusetts General Hospital (MGH) was a lead clinical research site after serving as
ADC Has Curative Effect On Cell Surface Protein In Neuroblastoma
ADC Has Curative Effect On Cell Surface Protein In Neuroblastoma
Physician-scientists in the Cancer Center at Children's Hospital of Philadelphia (CHOP) have developed a preclinical, potent therapy attached to an antibody that targets a surface protein expressed in most childhood neuroblastomas, effectively killing cancer cells. The researchers published their findings today in Science Translational Medicine. In 2008, researchers discovered mutations in the anaplastic lymphoma kinase (ALK) gene as the major cause of the inherited form of neuroblastoma and showed that these same mutations

All 5 Releases


More Releases for PEG

Biopharma PEG Delivers Innovative PEG Solutions for Enhanced Drug Efficacy
Watertown, MA - October 24, 2024 - Biopharma PEG is excited to announce its extensive offerings of polyethylene glycol (PEG) products, including monofunctional, homobifunctional, heterobifunctional, and multi-arm PEGs, tailored for PEGylation in biopharmaceutical applications. With over 40 PEGylated drugs approved globally, the role of PEGylation in drug development is more critical than ever. PEGylation provides numerous advantages, such as improved solubility, enhanced stability, and increased circulation time in the bloodstream. By
Biopharma PEG Expands Multi-Arm PEG Product Line
Biopharma PEG, a leader in PEG derivatives, is excited to announce the expansion of its high-purity Multi-Arm PEG linker product line, catering to the evolving needs of the medical and bioorganic fields. These advanced PEG linkers are available in various functional groups and molecular weights ranging from 1k to 40k, offering unmatched versatility and performance for research and development in cutting-edge medical applications. "Biopharma PEG is committed to delivering high-purity multi-arm
Biopharma PEG Supplies PEG Products Used For Infectious Disease Vaccines
As of January 1, 2023, global vaccine development includes a total of 966 vaccine candidates, of which 23% (220) are traditional inactivated or attenuated vaccines. Advances in molecular technology have facilitated the development of other platforms, such as recombinant protein vaccines, nucleic acid vaccines, and viral vector vaccines, which have further diversified global vaccine development. Recombinant protein vaccines accounted for the largest proportion of all pipeline in development, 22% (215), due
Biopharma PEG Supplies PEG Products For Click Chemistry Reactions
What is "click chemistry"? "Click Chemistry", this is a literary name given to this kind of reaction by the Nobel Prize winner K.Burry Sharless, when the cards are put together, "click" (click). Simply put, it is to add two structures to two molecules respectively, and these two structures can be specifically combined to synthesize the required chemical molecules. One of the most famous click-chemistry reactions is the Cu-catalyzed azide-alkyne cycloaddition
Biopharma PEG Develops PEG Linkers for Antibody Drug Conjugates
Antibody-drug conjugate (ADC) is one of the fastest growing fields in tumor therapy, which consists of monoclonal antibody (Antibody), linker (Linker) and active drug (Payload). So far, there are only 15 drugs on the market in the world. However, with the development of some perfect antibody modification techniques, advanced site-specific coupling techniques and powerful small-molecule toxins, ADC drug research has mushroomed and a large number of ADC drugs are in
High Quality PEG Raw Materials From Biopharma PEG
Polyethylene glycol (PEG) is a polyether compound derived from petroleum with many applications, from industrial manufacturing to medicine. PEG is also known as polyethylene oxide (PEO) or polyoxyethylene (POE), it has wide variety of applications depending on the length of the polymer chain and the molecular weight of the final polymer. The synthesis of PEG is done by polymerizing ethylene oxide, the main ingredient in antifreeze, using a ring-opening